Su1162 Gastrointestinal Bleeding With Warfarin, Novel Oral Anticoagulants and Left Atrial Appendage Exclusion Device in Patients With Atrial Fibrillation: Network Meta-Analysis of Randomized Controlled Trials

Novel oral anticoagulants (NOAC) are extensively being used in atrial fibrillation (AF) patients for mitigating stroke risk as an alternative to warfarin. In those patients with higher bleeding risk, left atrial appendage exclusion devices are being used for decreasing stroke risk. We performed a network meta-analysis of all randomized controlled trials (RCT) to compare the relative efficacy of all these agents.
Source: Gastrointestinal Endoscopy - Category: Gastroenterology Authors: Tags: Sunday – ASGE poster Source Type: research